We're living in an extraordinary time in health care. The incidence and cost of lifestyle-related chronic health conditions has risen to levels unimagined just a few decades ago—it's estimated that more than half of American adults suffer from one or more chronic illnesses. At the same time, developments in genetic, cellular, and nutritional research have yielded exciting new insights into the environmental influences and biological mechanisms that affect an individual's genetic predisposition to chronic illness.

The convergence of these factors—as well as an ever-growing demand for safe, effective, and natural options for managing chronic illness—has created an unprecedented opportunity for forward-thinking companies like ours.

For more than 25 years, we’ve been dedicated to developing innovative, science-based, natural approaches to improve health. Today, we’re well positioned to meet society’s current—and emerging—most pressing health care needs, through:

• FirstLine Therapy®—our turnkey, clinically tested therapeutic lifestyle program that can be implemented in any clinical practice
• One of the largest and most diverse research and development teams in the natural products industry
• Leading-edge nutritional genomics and clinical research facilities
• State-of-the-art biotechnology instrumentation
• A unique product development model assuring predicted safety, efficacy, and bioavailability of natural formulas.

The future solution to chronic disease management is taking place now—at Metagenics.